CEPI Open Calls for Proposals
Funds global vaccine and biologic countermeasure developers to build responses for epidemic pathogens.
The Coalition for Epidemic Preparedness Innovations (CEPI) is an Oslo-headquartered international foundation established in 2017 by governments, philanthropies, and the World Economic Forum to fund the development of vaccines and biologic countermeasures against epidemic and pandemic threats. CEPI issues rolling Calls for Proposals (CFPs) against its published priority pathogen list, which include…
Vaccine candidates and biologic countermeasures against CEPI priority pathogens: Chikungunya, Coronaviruses, Disease X, Filoviruses (Ebola/Marburg), Lassa fever, Mpox, Nipah, Rift Valley fever.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
DocumentsGrant Checklist: Application Documents, Forms, and Examples
Use this grant checklist to see the documents, forms, narratives, budgets, evidence, and compliance attachments a grant application may require.
More from CEPI
All grants from this funder →CEPI Clinical Development Award — Focus Area 2
CEPI · Norway
Funds organizations conducting clinical trials of vaccine candidates against CEPI priority pathogens and viral families through CEPI's Innovations Call for Proposals.
CEPI FA2 Exploratory Award
CEPI · Norway
Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.
CEPI FA2 Preclinical Development Award
CEPI · Norway
Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.
Similar grants
Browse the directory →
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
WIPANO Patenting for Companies
🇩🇪BMWE · Germany
Funds German small and medium-sized enterprises protecting their own research and development results with patents and other industrial property rights through WIPANO.
Sprint Grant for Small Companies
🇫🇮Business Finland · Finland
Funds Finnish small companies seeking fast growth in technology through focused commercial acceleration support.
WIPANO Standards Participation for Companies
🇩🇪BMWE · Germany
Funds German companies with up to 1,000 employees taking part in national, European, and international standardization committees through WIPANO.
BBSRC Stand-alone LINK — Always Open
🇬🇧BBSRC · United Kingdom
Supports United Kingdom university and industry teams through LINK grants that share innovation ownership and risk.
EIC Pathfinder Challenge: Biotechnology for Healthy Ageing
🇪🇺EIC · European Union
Supports translating decades of ageing biology into biotech or pharma proofs-of-concept that prevent, delay or revert age-related disease.